AU2002354185A1 - Fused indole compound, process for producing the same, and use - Google Patents
Fused indole compound, process for producing the same, and useInfo
- Publication number
- AU2002354185A1 AU2002354185A1 AU2002354185A AU2002354185A AU2002354185A1 AU 2002354185 A1 AU2002354185 A1 AU 2002354185A1 AU 2002354185 A AU2002354185 A AU 2002354185A AU 2002354185 A AU2002354185 A AU 2002354185A AU 2002354185 A1 AU2002354185 A1 AU 2002354185A1
- Authority
- AU
- Australia
- Prior art keywords
- producing
- same
- indole compound
- fused indole
- fused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-385141 | 2001-12-18 | ||
JP2001385141A JP2003183283A (en) | 2001-12-18 | 2001-12-18 | Condensed indole compound, method for producing the same and application of the same |
PCT/JP2002/013175 WO2003051884A1 (en) | 2001-12-18 | 2002-12-17 | Fused indole compound, process for producing the same, and use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002354185A1 true AU2002354185A1 (en) | 2003-06-30 |
Family
ID=19187791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002354185A Abandoned AU2002354185A1 (en) | 2001-12-18 | 2002-12-17 | Fused indole compound, process for producing the same, and use |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2003183283A (en) |
AU (1) | AU2002354185A1 (en) |
WO (1) | WO2003051884A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090099165A1 (en) | 2003-10-14 | 2009-04-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
US7326712B2 (en) * | 2003-10-14 | 2008-02-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Substituted tricyclic compounds as protein kinase inhibitors |
MXPA06013996A (en) * | 2004-06-02 | 2007-02-08 | Takeda Pharmaceutical | Fused heterocyclic compound. |
DE102006062203A1 (en) * | 2006-12-22 | 2008-06-26 | Curacyte Discovery Gmbh | Substituted 5H-pyrimido [5,4-b] indoles as inducers of apoptosis in B-CLL cells |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL112248A0 (en) * | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
IL126351A0 (en) * | 1996-04-12 | 1999-05-09 | Warner Lambert Co | Irreversible inhibitors of tyrosine kinases |
ATE264318T1 (en) * | 1996-11-19 | 2004-04-15 | Amgen Inc | ARYL AND HETEROARYL SUBSTITUTED CONDENSED PYRROLES AS ANTI-INFLAMMATORY AGENTS |
EP1212326A4 (en) * | 1999-08-27 | 2003-08-20 | Icn Pharmaceuticals | PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
-
2001
- 2001-12-18 JP JP2001385141A patent/JP2003183283A/en not_active Withdrawn
-
2002
- 2002-12-17 AU AU2002354185A patent/AU2002354185A1/en not_active Abandoned
- 2002-12-17 WO PCT/JP2002/013175 patent/WO2003051884A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2003183283A (en) | 2003-07-03 |
WO2003051884A1 (en) | 2003-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002349477A1 (en) | Bicyclic derivative, process for producing the same, and use | |
AU2002366467A1 (en) | Diffusion film, electrode having the diffusion film, and process for producing diffusion film | |
AU2001294228A1 (en) | Benzimidazole compounds, process for producing the same and use thereof | |
AU2001292320A1 (en) | Benzylamine compound, process for producing the same, and intermediate therefor | |
AU2002318742A1 (en) | Pullulan-containing powder, process for producing the same and use thereof | |
AU2003288023A1 (en) | Process for the manufacture of 1,2-epoxy-3-chloropropane | |
AU2003275675A1 (en) | Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same | |
AU2002330042A1 (en) | Process for the preparation of 1,5-diarylpyrazoles | |
AU2003289176A1 (en) | 1,3-benzothiazinone derivatives, process for producing the same and use thereof | |
AU2001286188A1 (en) | Tricyclic heterocyclic compound, process for producing the same, and use thereof | |
AU2002354185A1 (en) | Fused indole compound, process for producing the same, and use | |
AU2002365372A1 (en) | New process | |
AU2002227966A1 (en) | Coniosetin and derivatives thereof, method for producing the same and use thereof | |
AU2001242750A1 (en) | Novel protein, process for producing the same and use thereof | |
AU2002348998A1 (en) | N-methyl-homocystines, use thereof and method for the production thereof | |
AU2003201857A1 (en) | Bisphosphine, process for producing the same, and use thereof | |
AU2002228404A1 (en) | Indoline derivative and process for producing the same | |
MXPA03006932A (en) | Indoline derivative and process for producing the same. | |
AU2002216364A1 (en) | Novel substance fki-1083 and process for producing the same | |
AU2001294181A1 (en) | Novel protein, process for producing the same and use thereof | |
AU2003216893A1 (en) | Phenethylacrylamide, methods for the production thereof and agents containing the same | |
AU2002328586A1 (en) | Benzazepine derivative, process for producing the same, and use | |
AU2002315818A1 (en) | Furoisoquinoline derivative, process for producing the same, and use | |
AU2002238981A1 (en) | Tricyclic heterocyclic compound, process for producing the same, and use | |
AU2002332236A1 (en) | Benzimidazole compound, process for producing the same, and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |